Authorization

Evolus to Participate in Two Upcoming Investor Conferences

NEWPORT BEACH, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of management will be participating in two upcoming virtual investor conferences.


Event:



H.C. Wainwright Global Life Sciences Conference



Format:



Fireside Chat & 1x1 Meetings



Date:



Tuesday, March 9, 2021



Time:



7:00am ET



Location:A A 



Webcast Link











Event:



Barclays Global Healthcare Conference



Format:A 



Fireside Chat & 1x1 Meetings



Date:



Wednesday, March 10, 2021



Time:



1:15pm a?? 1:40pm ET



Location:



i»?Webcast Link

Audio webcasts of Evolusa?? fireside chats at the H.C. Wainwright Global Life Sciences Conference and Barclays Global Healthcare Conference will be available on the investor relations section of Evolusa?? website at investors.evolus.com. Replays of the webcasts will be available for 90 days after the date of the presentation.
About Evolus, Inc.EvolusA is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. In 2019, theA U.S. Food and Drug AdministrationA approved Jeuveau (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Purea?? technology. Jeuveau is powered byA Evolus'A unique technology platform and is designed to transform the aesthetic market by eliminating the friction points existing for customers today. Visit us at:A www.evolus.com.Jeuveau is a registered trademark of Evolus, Inc.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Апрель 2021    »
ПнВтСрЧтПтСбВс
 1234
567891011
12131415161718
19202122232425
2627282930